Myrobalan Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 10, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $24,000,000
Company Info
- Company Description
- Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.
- Market
- CNS conditions
- Location
- Medford, Massachusetts, USA
- Coinvestors
- 3E Bioventures, AB Magnitude Ventures Group, Co-win Ventures, Guan Zi Equity Investment